|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09939 KINTOR PHARMA-B
Nominal 
2.240 -0.040 (-1.754%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (199,080) | (387,581) | (961,260) | (1,051,363) |
| Net Cash from / (used in) Investing Activities | -- | 20,034 | 3,274 | 67,195 | 92,005 |
| Net Cash from / (used in) Financing Activities | -- | (119,671) | (33,463) | 815,750 | 857,418 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (298,717) | (417,770) | (78,315) | (101,940) |
| Cash & Cash Equivalents at beginning of period | -- | 444,027 | 864,470 | 926,331 | 1,064,689 |
| Effect of Foreign Exchange Rate Changes | -- | 2,109 | (2,673) | 16,454 | (36,418) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 147,419 | 444,027 | 864,470 | 926,331 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -83,268 |
| %Change | 16.470% |
| EPS / (LPS) | RMB -0.190 |
| NBV Per Share (¥) | RMB 0.483 |